Dhr. S. (Srdjan) Jovetic M.Sc: “Deacylation of glycopeptide antibiotic A40926 by immobilized Actinoplanes teichomyceticus cells – In quest of better drugs against MRSA”

  Nieuws
  Perskamer
  Archief
  Agenda
  2012
  2011
  2010
  2009
  2008
  2007
  2006
  2005
  2004
  2003
  2002
  2001
  2000
  1999
  Nieuws
  RSS
  Agenda
  Open dagen
  Cursussen
  Promoties & Oraties
  Congressen en symposia

5 jan 2010 16:00
Locatie: Aula, gebouw 362, Gen. Foulkesweg 1, Wageningen
Organisatie: Wageningen University
Promotor: prof.dr.ir. J. Tramper (Bioprocestechnologie)
Co-Promotor: Prof.dr. F. Marinelli (University of Insubria, Italy)

 A40926 is a natural glycopeptide antibiotic with a strong inhibitory activity against Gram-positive bacteria. By deacylation of A40926 an intermediate is produced that could be used for the synthesis of novel derivatives. These derivatives are defined as second-generation glycopeptides and are specifically designed  to be better drugs for the treatment of beta-lactam resistant Staphyloccous aureus and Staphylococcus epidermidis infections. In this thesis we studied and developed a lab-scale process for deacylation of A40926 using immobilized cells of Actinoplanes teichomyceticus.

Title:  Deacylation of glycopeptide antibiotic A40926 by immobilized Actinoplanes teichomyceticus cells - In quest of better drugs against MRSA
Print dit agenda item